Welcoming 2025—A Year of Collaboration and Progress

Gregory Y. H. Lip; Anne Rigby; Christian Weber

doi:10.1055/a-2495-2105

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2025; 125(01): 001-002
DOI: 10.1055/a-2495-2105

Editorial

Welcoming 2025—A Year of Collaboration and Progress

Authors

Gregory Y. H. Lip

¹Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom

²Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Anne Rigby

³Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany
Christian Weber

³Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany

⁴German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany

⁵Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands

Abstract

Full Text

References

References
1 Potpara T, Romiti GF, Sohns C. The 2024 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective. Thromb Haemost 2024; 124 (12) 1087-1094
2 Bejjani A, Bikdeli B. Direct oral anticoagulants: quick primer on when to use and when to avoid. Thromb Haemost 2024; (e-pub ahead of print).
3 Wang Y, Guo Y, Qin M. et al; Expert Reviewers. 2024 Chinese Expert Consensus Guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary. Thromb Haemost 2024; 124 (10) 897-911
4 Mackay GA, Gall C, Jampana R, Sleith C, Lip GYH. SIGN Dementia Guideline Development Group. Scottish Intercollegiate Guidelines Network guidance on dementia: the investigation of suspected dementia (SIGN 168) with focus on biomarkers—executive summary. Thromb Haemost 2024; (e-pub ahead of print).
5 Ortega-Martorell S, Olier I, Ohlsson M, Lip GYH. TARGET Consortium. TARGET: a major European project aiming to advance the personalised management of atrial fibrillation-related stroke via the development of health virtual twins technology and artificial intelligence. Thromb Haemost 2024; (e-pub ahead of print).
6 Hristov M, Weber C. Monocyte subsets in cardiovascular disease: a biomarker perspective. Thromb Haemost 2024; (e-pub ahead of print).
7 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2024 Editors' Choice Papers. Thromb Haemost 2025; 125 (01) 85-91
8 Rigby A, Albisetti M, Favaloro EJ. et al. Reflections on World Thrombosis Day 2024. Thromb Haemost 2024; (e-pub ahead of print).